BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24739903)

  • 21. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
    Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
    PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.
    Li J; Zhang J; Tang W; Mizu RK; Kusumoto H; XiangWei W; Xu Y; Chen W; Amin JB; Hu C; Kannan V; Keller SR; Wilcox WR; Lemke JR; Myers SJ; Swanger SA; Wollmuth LP; Petrovski S; Traynelis SF; Yuan H
    Hum Mutat; 2019 Dec; 40(12):2393-2413. PubMed ID: 31429998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-terminal alternative splicing of GluN1 regulates the maturation of excitatory synapses and seizure susceptibility.
    Liu H; Wang H; Peterson M; Zhang W; Hou G; Zhang ZW
    Proc Natl Acad Sci U S A; 2019 Oct; 116(42):21207-21212. PubMed ID: 31570583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 region.
    Adams J; Crosbie J; Wigg K; Ickowicz A; Pathare T; Roberts W; Malone M; Schachar R; Tannock R; Kennedy JL; Barr CL
    Mol Psychiatry; 2004 May; 9(5):494-9. PubMed ID: 14699423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment.
    Huh SJ; Chen YL; Friedman SL; Liao J; Huang HJ; Cavenee WK; Robertson GP
    J Natl Cancer Inst; 2010 Aug; 102(15):1131-47. PubMed ID: 20660366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
    Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
    Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of functional GRIN2A gene promoter polymorphisms with schizophrenia and serum D-serine levels.
    Liu R; Dang W; Du Y; Zhou Q; Liu Z; Jiao K
    Gene; 2015 Aug; 568(1):25-30. PubMed ID: 25958346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of GRIN2A in benign and malignant nasopharyngeal diseases and its clinical significance.
    Zhou XJ; Lin BR; Wang Y
    Genet Mol Res; 2015 Dec; 14(4):17289-95. PubMed ID: 26681223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathogenic S688Y mutation in the ligand-binding domain of the GluN1 subunit regulates the properties of NMDA receptors.
    Skrenkova K; Song JM; Kortus S; Kolcheva M; Netolicky J; Hemelikova K; Kaniakova M; Krausova BH; Kucera T; Korabecny J; Suh YH; Horak M
    Sci Rep; 2020 Oct; 10(1):18576. PubMed ID: 33122756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivo.
    Fujita M; Norris DA; Yagi H; Walsh P; Morelli JG; Weston WL; Terada N; Bennion SD; Robinson W; Lemon M; Maxwell IH; Yohn JJ
    Melanoma Res; 1999 Jun; 9(3):279-91. PubMed ID: 10465584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
    Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
    J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation.
    Mathieu V; Pirker C; Schmidt WM; Spiegl-Kreinecker S; Lötsch D; Heffeter P; Hegedus B; Grusch M; Kiss R; Berger W
    Oncotarget; 2012 Apr; 3(4):399-413. PubMed ID: 22535842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel missense mutation in GRIN2A causes a nonepileptic neurodevelopmental disorder.
    Fernández-Marmiesse A; Kusumoto H; Rekarte S; Roca I; Zhang J; Myers SJ; Traynelis SF; Couce ML; Gutierrez-Solana L; Yuan H
    Mov Disord; 2018 Jul; 33(6):992-999. PubMed ID: 29644724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanoma researchers have a reason to GRIN: melanoma yields more of its secrets to exome sequencing.
    Meltzer P
    Pigment Cell Melanoma Res; 2011 Aug; 24(4):590-1. PubMed ID: 21592317
    [No Abstract]   [Full Text] [Related]  

  • 35. Long noncoding RNA ILF3-AS1 promotes cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma.
    Chen X; Liu S; Zhao X; Ma X; Gao G; Yu L; Yan D; Dong H; Sun W
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective influences of N-acetylcysteine against alcohol abstinence-induced depression by regulating biochemical and GRIN2A, GRIN2B gene expression of NMDA receptor signaling pathway in rats.
    Yawalkar R; Changotra H; Gupta GL
    Neurochem Int; 2018 Sep; 118():73-81. PubMed ID: 29704590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
    Loria R; Bon G; Perotti V; Gallo E; Bersani I; Baldassari P; Porru M; Leonetti C; Di Carlo S; Visca P; Brizzi MF; Anichini A; Mortarini R; Falcioni R
    Oncotarget; 2015 Feb; 6(5):2779-93. PubMed ID: 25576923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis.
    Hendricks WPD; Zismann V; Sivaprakasam K; Legendre C; Poorman K; Tembe W; Perdigones N; Kiefer J; Liang W; DeLuca V; Stark M; Ruhe A; Froman R; Duesbery NS; Washington M; Aldrich J; Neff MW; Huentelman MJ; Hayward N; Brown K; Thamm D; Post G; Khanna C; Davis B; Breen M; Sekulic A; Trent JM
    PLoS Genet; 2018 Sep; 14(9):e1007589. PubMed ID: 30188888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma.
    Hwang S; Kim HE; Min M; Raghunathan R; Panova IP; Munshi R; Ryu B
    J Invest Dermatol; 2015 Sep; 135(9):2283-2291. PubMed ID: 25910030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclin D1 induction preceding neuronal death via the excitotoxic NMDA pathway involves selective stimulation of extrasynaptic NMDA receptors and JNK pathway.
    Efthimiadi L; Farso M; Quirion R; Krantic S
    Neurodegener Dis; 2012; 10(1-4):80-91. PubMed ID: 22354185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.